Table 3.
primary and secondary outcomes of the study
| Variable | No AF N=40,149 | Preexisting AF N=29,563 | New-onset AF N=2,948 | P value |
|---|---|---|---|---|
| 30-day HF readmission | 1.5 | 3.3 | 9.4 | <0.001 |
| 30-day stroke admission | 2.4 | 2.3 | 6.4 | <0.001 |
| 30-day bleed admission | 1.0 | 1.2 | 3.8 | <0.001 |
| 30-day mortality | 2.6 | 4.6 | 2.8 | <0.001 |
| New PPM in same TAVR admission | 25.3 | 24.9 | 28.2 | 0.0004 |
| Long-term follow up event rates, per 100 person-year | ||||
| HF readmission | 6.3 | 13.6 | 25.2 | <0.0001 |
| Any bleeding | 3.1 | 7.7 | 12.4 | <0.0001 |
| Stroke | 2.6 | 2.9 | 5.7 | <0.0001 |
| All-cause mortality | 12.8 | 22.6 | 29.7 | <0.0001 |